Cargando…
The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391229/ https://www.ncbi.nlm.nih.gov/pubmed/34714106 http://dx.doi.org/10.18553/jmcp.2021.27.11.1613 |
| _version_ | 1785082658430124032 |
|---|---|
| author | Synnott, Patricia G Whittington, Melanie D Lin, Grace A Rind, David M Pearson, Steven D |
| author_facet | Synnott, Patricia G Whittington, Melanie D Lin, Grace A Rind, David M Pearson, Steven D |
| author_sort | Synnott, Patricia G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10391229 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103912292023-08-02 The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum Synnott, Patricia G Whittington, Melanie D Lin, Grace A Rind, David M Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2021-11 /pmc/articles/PMC10391229/ /pubmed/34714106 http://dx.doi.org/10.18553/jmcp.2021.27.11.1613 Text en Copyright © 2021, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Synnott, Patricia G Whittington, Melanie D Lin, Grace A Rind, David M Pearson, Steven D The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title | The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_full | The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_fullStr | The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_full_unstemmed | The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_short | The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum |
| title_sort | effectiveness and value of aducanumab for alzheimer’s disease: a summary from the institute for clinical and economic review’s california technology assessment forum |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391229/ https://www.ncbi.nlm.nih.gov/pubmed/34714106 http://dx.doi.org/10.18553/jmcp.2021.27.11.1613 |
| work_keys_str_mv | AT synnottpatriciag theeffectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT whittingtonmelanied theeffectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT lingracea theeffectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT rinddavidm theeffectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT pearsonstevend theeffectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT synnottpatriciag effectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT whittingtonmelanied effectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT lingracea effectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT rinddavidm effectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum AT pearsonstevend effectivenessandvalueofaducanumabforalzheimersdiseaseasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum |